Functionalized polymersomes for biomedical applications
文献信息
Prasad V. Pawar, Shalini V. Gohil, Jay Prakash Jain, Neeraj Kumar
Polymersomes are latest entry to the drug carrier systems and have proven their utility to deliver therapeutic agents to specific tissues/organs due to their versatile polymeric architectures and self-assembly of polymeric chains into vesicular containers of therapeutic agents. Recent research has focused on the development of multi-functional polymersomes as targeted drug delivery systems for combined therapeutic applications and theranostic applications where therapeutic delivery via passive or active targeting can be simultaneously combined with diagnostic capabilities. Functionalized polymersomes have been prepared by (a) conjugation of functional ligands to preformed polymeric vesicles, (b) self-assembly of end-group functionalized block copolymers, or (c) use of polymers with functionalized hydrophilic blocks. This review focuses on various strategies used for developing functionalized polymersomes, as a means to achieve multiple goals of therapy as well as diagnosis by use of specific ligands, while maintaining their ability to encapsulate and deliver desired therapeutic or diagnostic principles. Various ligands used for such functionalization have been discussed with a focus on cellular/tissue targeting as well as other biomedical applications of the same.
相关文献
Defects in crystalline PVDF: a density functional theory-density functional tight binding study
Saeid Arabnejad, Koichi Yamashita, Sergei Manzhos
DOI: 10.1039/C7CP00510E
Interfacial engineering of hole transport layers with metal and dielectric nanoparticles for efficient perovskite solar cells
Dian Wang, Kah H. Chan, Naveen Kumar Elumalai, Md. Arafat Mahmud, Mushfika B. Upama, Ashraf Uddin, Supriya Pillai
DOI: 10.1039/C7CP04053A
Non-covalent interactions in anisole–(CO2)n (n = 1, 2) complexes
Jan Řezáč, Dana Natchigallová, Pavel Hobza
DOI: 10.1039/C7CP03763E
Tailoring the physical properties of the mixtures of ionic liquids: a microscopic point of view
O. Palumbo, M. A. Navarra, J.-B. Brubach, P. Roy, A. Paolone
DOI: 10.1039/C7CP00850C
Pd-P nanoparticles supported on PxOy-incorporated carbon nanotubes for enhanced methanol oxidation in an alkaline medium
Yanan Xie, Weizhen Yu, Juan Wang, Yifei Wu, Shuo Niu, Wenyao Guo, Tsungwu Lin, Lidong Shao
DOI: 10.1039/C7CP04540A
Exciton transport in π-conjugated polymers with conjugation defects
Ruixuan Meng, Yuan Li, Chong Li, Kun Gao, Sun Yin, Luxia Wang
DOI: 10.1039/C7CP02626A
Origin of non-conservative circular dichroism of the CP29 antenna complex of photosystem II
Dominik Lindorfer, Frank Müh, Thomas Renger
DOI: 10.1039/C6CP08778G
您可能还喜欢
(3-氨苯基)环丙基甲酮(CAS号:162174-75-6)的主要用途是什么?
(3-氨苯基)环丙基甲酮主要用于合成化学中间体,特别是在药物化学领域作为原料。它还可以用于有机合成反应中,作为催化剂或反应物。
如何储存亚胺菌(CAS号:136470-79-6)?
亚胺菌应储存在干燥、阴凉处,避免直接暴露于光线下。建议使用密封容器储存,防止吸潮和污染。具体的储存条件应参考产品的安全数据表(MSDS)或药品说明书。
2-氯-2,2-二氟乙酰胺(CAS号:354-28-9)应用于哪些行业?
2-氯-2,2-二氟乙酰胺在医药、聚合物、传感器、半导体等领域有广泛应用。在医药领域,它作为中间体用于合成其他药物;在聚合物领域,用作聚合引发剂或稳定剂;在传感...
处理4-甲基-3-硝基-1,1-联苯(CAS号:53812-68-3)时应注意哪些实验室安全事项?
在处理4-甲基-3-硝基-1,1-联苯时,应佩戴手套、护目镜和实验室外套等个人防护装备(PPE),确保在通风橱中操作以减少吸入风险。若发生泄露,应立即使用沙子或...
(2S)-羟基(苯基)乙酸 (2R)-N-苄基-1-(4-甲氧基苯基)丙-2-胺盐(CAS号:188690-84-8)应用于哪些行业?
该化合物广泛应用于医药、聚合物和半导体行业。在医药领域,它是某些药物中间体的重要组成部分;在聚合物领域,可用作增塑剂;在半导体行业,可用于制造光刻胶。
在合成中是否有芬苯哒唑砜-D3标准品(CAS号:1228182-49-7)的替代品?
芬苯哒唑砜-D3标准品的替代品可能包括类似的苯并咪唑类化合物,如芬苯哒唑本身或其非同位素标记版本。这些替代品在结构上与芬苯哒唑砜-D3相似,但在具体应用中需进行...
2-氟-4-硝基苯乙酸(CAS号:315228-19-4)通常如何合成?
2-氟-4-硝基苯乙酸可以通过一系列化学反应合成,通常是从4-氟苯胺开始,首先进行硝化反应生成4-氟-2-硝基苯胺,然后进行乙酰化反应得到目标产物。具体的合成步...
2-氟-4-甲氧基苯乙酸(CAS号:883531-28-0)通常如何合成?
2-氟-4-甲氧基苯乙酸通常通过将4-甲氧基苯乙酸与氟化试剂(如氟化氰)反应来合成。反应通常在无水条件下进行,使用催化剂如六氟磷酸锂或四氟硼酸锂以提高选择性和产...
什么是4SC 202;4SC202(CAS号:1186222-89-8)?
4SC 202;4SC202是一种化学化合物,其化学名称为(2E)-N-(2-氨基苯基)-3-(1-{[4-(1-甲基-1H-吡唑-4-基)苯基]磺酰基}-1H...
来源期刊
Polymer Chemistry

Polymer Chemistry welcomes submissions in all areas of polymer science that have a strong focus on macromolecular chemistry. Manuscripts may cover a broad range of fields, yet no direct application focus is required.










![(2E)-4-[(1R,2S,8R,19S,21R)-14-Hydroxy-11-isopropenyl-8,23,23-trimethyl-5-(3-methyl-2-buten-1-yl)-16,20-dioxo-3,7,22-trioxaheptacyclo[17.4.1.1~8,12~.0~2,17~.0~2,21~.0~4,15~.0~6,13~]pentacosa-4(15),5,13
,17-tetraen-21-yl]-2-methyl-2-butenoic acid structure (2E)-4-[(1R,2S,8R,19S,21R)-14-Hydroxy-11-isopropenyl-8,23,23-trimethyl-5-(3-methyl-2-buten-1-yl)-16,20-dioxo-3,7,22-trioxaheptacyclo[17.4.1.1~8,12~.0~2,17~.0~2,21~.0~4,15~.0~6,13~]pentacosa-4(15),5,13
,17-tetraen-21-yl]-2-methyl-2-butenoic acid structure](https://cnstatic.chemtradehub.com/structs/173/173867-04-4-d2d3.webp)

![2-[({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)methyl]isonicotinic acid structure 2-[({[(2-Methyl-2-propanyl)oxy]carbonyl}amino)methyl]isonicotinic acid structure](https://cnstatic.chemtradehub.com/structs/473/473924-63-9-973b.webp)

